BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33801766)

  • 21. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.
    Sio TT; Lin HK; Shi Q; Gunn GB; Cleeland CS; Lee JJ; Hernandez M; Blanchard P; Thaker NG; Phan J; Rosenthal DI; Garden AS; Morrison WH; Fuller CD; Mendoza TR; Mohan R; Wang XS; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1107-14. PubMed ID: 27354125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
    Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
    Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative In Silico Analysis of Ultra-Hypofractionated Intensity-Modulated Photon Radiotherapy (IMRT) Versus Intensity-Modulated Proton Therapy (IMPT) in the Pre-Operative Treatment of Retroperitoneal Sarcoma.
    Gogineni E; Chen H; Istl AC; Johnston FM; Narang A; Deville C
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
    Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
    Front Oncol; 2019; 9():1456. PubMed ID: 31998635
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
    Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
    BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
    Beckham TH; Romesser PB; Groen AH; Sabol C; Shaha AR; Sabra M; Brinkman T; Spielsinger D; McBride S; Tsai CJ; Riaz N; Tuttle RM; Fagin JA; Sherman EJ; Wong RJ; Lee NY
    Thyroid; 2018 Sep; 28(9):1180-1189. PubMed ID: 30105947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
    Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
    Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-Modulated Proton and Carbon-Ion Radiation Therapy in the Management of Head and Neck Sarcomas.
    Yang J; Gao J; Qiu X; Hu J; Hu W; Wu X; Zhang C; Ji T; Kong L; Lu JJ
    Cancer Med; 2019 Aug; 8(10):4574-4586. PubMed ID: 31231939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Dosimetric Comparison of Intensity-Modulated Proton Therapy, Volumetric-Modulated Arc Therapy, and 4π Non-Coplanar Intensity-Modulated Radiation Therapy for a Patient with Parameningeal Rhabdomyosarcoma.
    Chen TW; Sison J; Lee B; Olch AJ; Chang A; Giebeler A; Wong K
    Cureus; 2017 Sep; 9(9):e1673. PubMed ID: 29152430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
    Cao J; Zhang X; Jiang B; Chen J; Wang X; Wang L; Sahoo N; Zhu XR; Ye R; Blanchard P; Garden AS; Fuller CD; Gunn GB; Frank SJ
    Radiother Oncol; 2021 Jul; 160():32-39. PubMed ID: 33839202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
    Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
    Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
    Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
    Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
    [No Abstract]   [Full Text] [Related]  

  • 39. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
    MacDonald SM; Safai S; Trofimov A; Wolfgang J; Fullerton B; Yeap BY; Bortfeld T; Tarbell NJ; Yock T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):979-86. PubMed ID: 18325681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.